about
Expression of human alpha-globin and mouse/human hybrid beta-globin genes in murine hemopoietic stem cells transduced by recombinant retroviruses.Phenotypic correction of factor IX deficiency in skin fibroblasts of hemophilic dogsExpression of human factor IX in rabbit hepatocytes by retrovirus-mediated gene transfer: potential for gene therapy of hemophilia B.Haemophilias: advances towards genetic engineering replacement therapy.Systemic distribution of apolipoprotein E secreted by grafts of epidermal keratinocytes: implications for epidermal function and gene therapy.Canine hemophilia B resulting from a point mutation with unusual consequencesIntraarticular expression of biologically active interleukin 1-receptor-antagonist protein by ex vivo gene transferSustained delivery of erythropoietin in mice by genetically modified skin fibroblastsGene therapy for haemophilia.Cellular and humoral immune responses to adenoviral vectors containing factor IX gene: tolerization of factor IX and vector antigens allows for long-term expressionGene therapy for vascular diseases.Gene transfer to epidermal stem cells: implications for tissue engineering.Long-term production and delivery of human growth hormone in vivoHighly efficient and sustained gene transfer in adult neurons with a lentivirus vector.A factor IX-deficient mouse model for hemophilia B gene therapy.Direct injection of a recombinant retroviral vector induces human immunodeficiency virus-specific immune responses in mice and nonhuman primatesExpression of human factor IX in mice after injection of genetically modified myoblastsGene therapy via primary myoblasts: long-term expression of factor IX protein following transplantation in vivoTransgene-specific host responses in cutaneous gene therapy: the role of cells expressing the transgene.Therapeutic levels of human protein C in rats after retroviral vector-mediated hepatic gene therapy.Genetically modified skin fibroblasts persist long after transplantation but gradually inactivate introduced genes.Long-term in vivo expression of retrovirus-mediated gene transfer in mouse fibroblast implants.Expression of human factor IX in rat capillary endothelial cells: toward somatic gene therapy for hemophilia BDrug delivery by genetically engineered cell implants.Long-term transplantation of canine keratinocytes made resistant to G418 through retrovirus-mediated gene transfer.Slow and Steady Wins The Race? Progress in the Development of Vectors for Gene Therapy of β-Thalassemia and Sickle Cell Disease.Long-term silencing of retroviral vectors is resistant to reversal by trichostatin A and 5-azacytidine.Engineered pluripotent mesenchymal cells integrate and differentiate in regenerating bone: a novel cell-mediated gene therapy.Microencapsulation and transplantation of genetically engineered cells: a new approach to somatic gene therapy.Single cell analysis and selection of living retrovirus vector-corrected mucopolysaccharidosis VII cells using a fluorescence-activated cell sorting-based assay for mammalian beta-glucuronidase enzymatic activity.A novel endothelial cell-based gene therapy platform for the in vivo delivery of apolipoprotein E.Sustained gene expression in transplanted skin fibroblasts in rats.Progress toward the treatment of arthritis by gene therapy.Engineering dynamics of growth factors and other therapeutic ligands.Subcutaneous injection of factor IX for the treatment of haemophilia B.The role of gene therapy in haemophilia.A single adenovirus vector mediates doxycycline-controlled expression of tyrosine hydroxylase in brain grafts of human neural progenitors.
P2860
Q33619761-CC6F9220-C65E-4924-A65F-DD23B454E4E0Q33671665-AE1B053B-6028-4F38-8B03-27A95B9B121CQ33739384-156F2663-6052-4023-B862-CB6466379D0CQ34229310-A370D58F-EE03-4B49-8FC3-47B0821DF4C7Q34319054-BF9CC67A-E9F4-44B2-8F4A-15474F7A6EAFQ34326780-17050AD1-599E-4F60-9CB0-6567968BEAFAQ34345395-554A2EC6-B0A0-4D7C-B042-DB75871879F6Q34421635-3EAFE282-BA9A-4EA5-9A01-DDA1548473BBQ34530130-E08A1EEB-7FA7-45A0-A4B4-14B1B29D512BQ34615481-EC86A183-73A1-44FA-B6C8-4832E856E583Q35652189-1E40602B-E2CB-48DC-8060-2029486E9F8FQ35790824-D42C749B-5F4E-4AA6-A034-F6DFA5310322Q35888390-37920A8C-2BAF-4DE8-8AC9-61FD8A477EA1Q35891440-16AF80A8-F0D0-4207-945A-E8F9F0518F5BQ36602472-CF21E5E2-24FE-484A-8414-2B5803227113Q36624976-E60D5E7D-D5DB-42BA-99C3-F51B9CDB3211Q36950396-B6116334-E689-4CE7-86B8-25B31286CCCEQ37300317-1D71FA78-8650-4872-9DF0-F4E959E15861Q37341382-301A30C4-BC18-4F4E-8992-5350EADB26B3Q37383736-33B9F85D-4D7A-4289-8136-BC22DE71DD1CQ37401979-ED688747-0D4B-41D9-9CF0-41D0CF77A386Q37518848-35BBB65E-3E42-429A-BEEC-ABEA08BE0DAEQ37594306-D9C20D42-CBDE-41AC-973E-2D069532F8C1Q37672799-DF59ACB1-D126-4A7C-82E5-6A13D0B31C4BQ37723721-A4AFB118-AC21-4D9E-B7E2-156498E9A116Q38900001-EFE487F7-D06C-4F1E-94B7-FE1B2ECECEE4Q40881551-D11867E8-7977-4EFC-83BB-7CA90630A81AQ40890770-CB64999E-D55C-4795-B8B9-CAE811D3A705Q41200886-98EFC5A3-BB9A-4969-B123-2D0F076313D9Q45854840-B6089C26-0616-4D63-A3BE-579B1F1DA882Q45861575-9B8FA076-27F1-4ED0-8D7C-2D776CA0A136Q45862567-EAD25BF1-D04A-4CA7-99B4-519507610661Q45875538-1A32F6DE-96C4-4665-A713-9E156F95C519Q45878993-CB8AB16D-240D-4D54-9A10-34AD8FA5048EQ45879297-60E8EA50-08BF-4719-978F-BA8A5D5CCF17Q45887118-1C7563DE-A40F-4F1C-9EE6-38D967F52A26Q48233698-722306C7-9AEC-48A4-B272-A77D63FB0FD4
P2860
description
1988 nî lūn-bûn
@nan
1988 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1988 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1988年の論文
@ja
1988年論文
@yue
1988年論文
@zh-hant
1988年論文
@zh-hk
1988年論文
@zh-mo
1988年論文
@zh-tw
1988年论文
@wuu
name
An alternative approach to somatic cell gene therapy.
@ast
An alternative approach to somatic cell gene therapy.
@en
An alternative approach to somatic cell gene therapy.
@nl
type
label
An alternative approach to somatic cell gene therapy.
@ast
An alternative approach to somatic cell gene therapy.
@en
An alternative approach to somatic cell gene therapy.
@nl
prefLabel
An alternative approach to somatic cell gene therapy.
@ast
An alternative approach to somatic cell gene therapy.
@en
An alternative approach to somatic cell gene therapy.
@nl
P2860
P356
P1476
An alternative approach to somatic cell gene therapy.
@en
P2093
P2860
P304
P356
10.1073/PNAS.85.9.3150
P407
P577
1988-05-01T00:00:00Z